The Digital Revolution: The Genesis of Patient-Driven Healthcare

Digital technology is reshaping the very contours of modern healthcare with the potential to sustainably transform the industry as we know it.

The broad scope of digital health, as defined by the FDA, includes categories such as health information technology, telehealth, wearable devices, telemedicine and personalised medicine.  By converging digital health and genomic technologies with everyday living, society and healthcare, the digital revolution is empowering new-age consumers to better manage, track and improve their health. Ultimately, enhancing the way healthcare providers interact and deliver care improves the health journey for each patient.  

The digital revolution has become embedded into the very fabrics of the healthcare system, breaking down the barriers that previously separated healthcare providers from their patients. By equalising the power between patient and provider patients are, for the first time, able to better navigate and captain their medical journey. As such, the evolution of healthcare is beginning to reform aspects of the healthcare paradigm. This has resulted in the remodelling of prevention, diagnosis, management and treatment systems and has changed the way healthcare services are created, delivered and measured.

The digitalisation platform is allowing healthcare providers to transform two core aspects at the very heart of care delivery:

  1. Integrated care and the patient experience; and
  2. Data analytics in achieving quality diagnostics.
Integrated Care and the Patient Experience

Integrated care focuses on the coordinated forms of care provision for the benefit of patients, as well as their families, and the impact they have on greater society. To achieve this, transmural care systems improve access to information, providing innovative ways for patients to monitor their health and well-being.

The digital health revolution recognises that the modern patient has an appetite for taking charge of their health journey and empowers them to champion their treatment and/or management plan. Considering 57% of patients own or use a connected care device, the modern patient is well-informed, self-reliant and empowered. By removing the barrier that previously separated patients from healthcare practitioners, digital health is building a platform where patients and healthcare professionals can interact. Facilitating open and dynamic communication between the patient and their provider not only improves quality performance but service efficiency.

Improving Diagnostics and Treatment

The facilitation of global connectivity created by the digital revolution has increased the pool of data made available to not only healthcare providers, but the wider community. This has unlocked a trove of data derived from electronic health records, wearables, biosensing devices and more. Patients and practitioners can work collaboratively using this data to better inform patient care, diagnosis and treatment to enhance precision medicine. Larger samples of data improve predictive models enabling more targeted, accurate and timely care.

About The iQ Group Global

The iQ Group Global is a bioscience investment enterprise that finds, funds and develops life science discoveries to create life-changing medical innovations. The Group’s flagship innovation is the Saliva Glucose Biosensor, in development as the first non-invasive replacement for the finger-prick blood glucose testing for people living with diabetes. Read more: The iQ Group Global.

“At The iQ Group Global we are not only embracing but driving the revolution forward” – Dr George Syrmalis, Group CEO of The iQ Group Global.

By embracing the digital health revolution, The iQ Group Global has and continues to unlock opportunities in the life-science sector, with a particular focus on disease prevention and healthcare promotion. The Group is leveraging the development and growth of the medical and biotechnology industries so they can better respond to the changing needs of the ‘empowered patient’.

The iQ Group Global’s biosensor diagnostic and monitoring platform champions this approach. By integrating advanced biosensor technology with a promising digital care platform, patients can access results in real-time. The biosensor platform enables the testing of more than 130 biomarkers in a human saliva sample, ranging from glucose for diabetes management to various analytes of infectious diseases.

Media Contact

Get in touch with our media representative below.

Meet the people bringing our technology to life